DIA/FDA Statistics Forum

The DIA/FDA Statistics Forum fosters open discussion of timely topics of mutual theoretical and practical interest to biostatisticians and clinical trialists.

返回 Agenda

Keynote Address(es)

Session Chair(s)

Dionne Price, PhD

Deputy Director, Office of Biostatistics, OTS, CDER

FDA, United States

Speaker(s)

Session Co-Chair

Jerald Schindler, DrPH

Strategic Statistics, United States

Chief Executive Officer

The 21st Century Vision for New Drug Review at CDER and the Role of Statisticians

Janet Woodcock, MD

United States

Retired, Principal Deputy Commissioner, FDA

The Times They Are A-Changin': How Economic Demands and Drug Development Challenges are Altering the Face of Pharmaceutical R&D

Kenneth I. Kaitin, PhD

Tufts Center for the Study of Drug Development, United States

Professor and Senior Fellow